• ABOUT GBR

  • AEROSPACE

  • CHEMICALS

  • MINING

  • PHARMACEUTICALS

INTERVIEWS MORE INTERVIEWS

AC Immune describes its research into neurodegenerative diseases.
Quotient Sciences is a drug development and manufacturing accelerator that supports pharmaceutical and biotech companies with services spanning the entire development pathway from candidate selection to commercial launch.
Liebherr explains how it is attempting to build up is share of the Canadian mining equipment market.
Nivagen Pharmaceuticals provides complete research, analytical formulation development, and regulatory support.

ARTICLES

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

The Global Tailings Standard

April 16, 2021
The mining industry and investment community are collaborating to mitigate a perpetual risk, after a series of high-profile disasters.

Tailings Management

April 16, 2021
Expert Opinion Article by Dan Etheredge, General Manager, Klohn Crippen Berger S.A.

Optimism Returns to Peru’s Mining Sector

March 21, 2021
Surging copper brings renewed optimism to Peru, but a pivotal election looms.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Mining in Ontario and Toronto's Global Reach 2021

PARTNER EVENTS